109 related articles for article (PubMed ID: 25899712)
1. Characterization of the roles of suppressor of cytokine signaling-3 in prostate cancer development and progression.
Fu X; Ren L; Chen J; Liao K; Fu Y; Qian X; Xiao J
Asia Pac J Clin Oncol; 2015 Jun; 11(2):106-13. PubMed ID: 25899712
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of suppressor of cytokine signaling-3 causes prostate cancer cell death through activation of the extrinsic and intrinsic apoptosis pathways.
Puhr M; Santer FR; Neuwirt H; Susani M; Nemeth JA; Hobisch A; Kenner L; Culig Z
Cancer Res; 2009 Sep; 69(18):7375-84. PubMed ID: 19738059
[TBL] [Abstract][Full Text] [Related]
3. Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinases.
Neuwirt H; Puhr M; Santer FR; Susani M; Doppler W; Marcias G; Rauch V; Brugger M; Hobisch A; Kenner L; Culig Z
Am J Pathol; 2009 May; 174(5):1921-30. PubMed ID: 19342366
[TBL] [Abstract][Full Text] [Related]
4. [Androgens stimulate the expression of SOCS-3 and inhibits their effect on proliferation and secretion].
Neuwirt H; Puhr M; Cavarretta IT; Mitterberger M; Hobisch A; Culig Z
Aktuelle Urol; 2009 Aug; 40(4):231-4. PubMed ID: 19634073
[TBL] [Abstract][Full Text] [Related]
5. Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretion.
Neuwirt H; Puhr M; Cavarretta IT; Mitterberger M; Hobisch A; Culig Z
Endocr Relat Cancer; 2007 Dec; 14(4):1007-19. PubMed ID: 18045952
[TBL] [Abstract][Full Text] [Related]
6. Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer.
Bellezza I; Neuwirt H; Nemes C; Cavarretta IT; Puhr M; Steiner H; Minelli A; Bartsch G; Offner F; Hobisch A; Doppler W; Culig Z
Am J Pathol; 2006 Dec; 169(6):2199-208. PubMed ID: 17148681
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of signal transducer and activator of transcription (STAT-3 and STAT-5) transcription factors and alteration of suppressor of cytokine signaling (SOCS-1) protein in prostate cancer.
Singh N; Hussain S; Bharadwaj M; Kakkar N; Singh SK; Sobti RC
J Recept Signal Transduct Res; 2012 Dec; 32(6):321-7. PubMed ID: 23134344
[TBL] [Abstract][Full Text] [Related]
8. Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.
Isomoto H; Mott JL; Kobayashi S; Werneburg NW; Bronk SF; Haan S; Gores GJ
Gastroenterology; 2007 Jan; 132(1):384-96. PubMed ID: 17241887
[TBL] [Abstract][Full Text] [Related]
9. [The Role of SOCS in the Development of Tumors].
Liu C; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2016 Sep; 19(9):620-5. PubMed ID: 27666555
[TBL] [Abstract][Full Text] [Related]
10. Significance of expression of suppressor of cytokine signaling proteins: Suppressor of cytokine signaling-1, suppressor of cytokine signaling-2, and suppressor of cytokine signaling-3 in papillary thyroid cancer.
Kobawala TP; Trivedi TI; Gajjar KK; Patel GH; Ghosh NR
J Cancer Res Ther; 2017; 13(2):337-345. PubMed ID: 28643757
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6: a multifunctional targetable cytokine in human prostate cancer.
Culig Z; Puhr M
Mol Cell Endocrinol; 2012 Sep; 360(1-2):52-8. PubMed ID: 21664423
[TBL] [Abstract][Full Text] [Related]
12. A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells.
Flowers LO; Subramaniam PS; Johnson HM
Oncogene; 2005 Mar; 24(12):2114-20. PubMed ID: 15688010
[TBL] [Abstract][Full Text] [Related]
13. Suppressors of cytokine signalling-3 and -1 in human carcinogenesis.
Culig Z
Front Biosci (Schol Ed); 2013 Jan; 5(1):277-83. PubMed ID: 23277051
[TBL] [Abstract][Full Text] [Related]
14. SOCS-3 antagonizes pro-apoptotic effects of TRAIL and resveratrol in prostate cancer cells.
Horndasch M; Culig Z
Prostate; 2011 Sep; 71(12):1357-66. PubMed ID: 21308719
[TBL] [Abstract][Full Text] [Related]
15. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer.
Iglesias-Gato D; Chuan YC; Wikström P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
Carcinogenesis; 2014 Jan; 35(1):24-33. PubMed ID: 24031028
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.
Chen T; Wang LH; Farrar WL
Cancer Res; 2000 Apr; 60(8):2132-5. PubMed ID: 10786674
[TBL] [Abstract][Full Text] [Related]
17. [Progress of study on suppressor of cytokine signaling-1 - review].
Yang HP; Dai M; Zhang DH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):437-40. PubMed ID: 17493365
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression.
Miyoshi H; Fujie H; Shintani Y; Tsutsumi T; Shinzawa S; Makuuchi M; Kokudo N; Matsuura Y; Suzuki T; Miyamura T; Moriya K; Koike K
J Hepatol; 2005 Nov; 43(5):757-63. PubMed ID: 16083990
[TBL] [Abstract][Full Text] [Related]
19. Suppressor of cytokine signaling 6 in cancer development and therapy: Deciphering its emerging and suppressive roles.
Yang Z; Huang S; Zhao L
Cytokine Growth Factor Rev; 2022 Apr; 64():21-32. PubMed ID: 35210167
[TBL] [Abstract][Full Text] [Related]
20. Role of SOCS1 in tumor progression and therapeutic application.
Zhang J; Li H; Yu JP; Wang SE; Ren XB
Int J Cancer; 2012 May; 130(9):1971-80. PubMed ID: 22025331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]